Hyfusin Group Holdings Limited (8512.HK)
HKD 0.24
(0.0%)
HKD 0.24
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 138.63 Million HKD | 41.55% |
| 2022 | 97.93 Million HKD | -29.12% |
| 2021 | 138.16 Million HKD | 19.0% |
| 2020 | 116.09 Million HKD | 237.3% |
| 2019 | 34.42 Million HKD | 284.5% |
| 2018 | 8.95 Million HKD | 217.6% |
| 2017 | -7.61 Million HKD | -160.64% |
| 2016 | 12.55 Million HKD | -19.66% |
| 2015 | 15.62 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 38.11 Million HKD | 0.0% |
| 2024 Q1 | 38.11 Million HKD | -40.63% |
| 2023 FY | 138.63 Million HKD | 41.55% |
| 2023 Q4 | 64.19 Million HKD | -21.28% |
| 2023 Q1 | 26.38 Million HKD | -4.85% |
| 2023 Q2 | 48.75 Million HKD | 84.77% |
| 2023 Q3 | 81.54 Million HKD | 67.26% |
| 2022 Q1 | 23.84 Million HKD | -37.36% |
| 2022 FY | 97.93 Million HKD | -29.12% |
| 2022 Q4 | 27.73 Million HKD | 30.24% |
| 2022 Q3 | 21.29 Million HKD | -13.44% |
| 2022 Q2 | 24.6 Million HKD | 3.17% |
| 2021 Q1 | 23.45 Million HKD | -51.63% |
| 2021 Q2 | 41.16 Million HKD | 75.55% |
| 2021 Q3 | 34.33 Million HKD | -16.59% |
| 2021 Q4 | 38.06 Million HKD | 10.87% |
| 2021 FY | 138.16 Million HKD | 19.0% |
| 2020 Q2 | 7.98 Million HKD | -22.38% |
| 2020 Q1 | 10.28 Million HKD | -45.38% |
| 2020 Q3 | 47.77 Million HKD | 498.2% |
| 2020 Q4 | 48.47 Million HKD | 1.47% |
| 2020 FY | 116.09 Million HKD | 237.3% |
| 2019 Q4 | 18.83 Million HKD | 22.82% |
| 2019 FY | 34.42 Million HKD | 284.5% |
| 2019 Q3 | 15.33 Million HKD | 878.23% |
| 2019 Q2 | -1.97 Million HKD | -48.44% |
| 2019 Q1 | -1.32 Million HKD | -187.45% |
| 2018 Q3 | 6.34 Million HKD | 367.49% |
| 2018 Q1 | -2.35 Million HKD | 62.02% |
| 2018 Q4 | 1.51 Million HKD | -76.08% |
| 2018 FY | 8.95 Million HKD | 217.6% |
| 2018 Q2 | 1.35 Million HKD | 157.74% |
| 2017 Q3 | 5.98 Million HKD | 262.92% |
| 2017 Q1 | -22.5 Thousand HKD | 0.0% |
| 2017 Q2 | -3.67 Million HKD | -16221.11% |
| 2017 Q4 | -6.19 Million HKD | -203.46% |
| 2017 FY | -7.61 Million HKD | -160.64% |
| 2016 FY | 12.55 Million HKD | -19.66% |
| 2015 FY | 15.62 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | -3.73 Million HKD | 3808.694% |
| Innovative Pharmaceutical Biotech Limited | -13.43 Million HKD | 1131.941% |
| China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | 5359.143% |
| Prosperous Future Holdings Limited | -30.27 Million HKD | 557.955% |
| Huasheng International Holding Limited | 994 Thousand HKD | -13846.781% |
| Fourace Industries Group Holdings Limited | 39.7 Million HKD | -249.117% |
| Evergreen Products Group Limited | 81.06 Million HKD | -71.018% |
| EC Healthcare | 186.03 Million HKD | 25.479% |
| Ming Fai International Holdings Limited | 144.06 Million HKD | 3.771% |
| Blue Moon Group Holdings Limited | 130.43 Million HKD | -6.284% |
| SuperRobotics Holdings Limited | -7.88 Million HKD | 1859.277% |
| Takbo Group Holdings Limited | 9.68 Million HKD | -1331.104% |